Publications by authors named "Katja Marin"

Claim this Profile
P
Prolonged Time From Symptoms to Diagnosis Is Associated With an Inferior Progression-Free Survival in Diffuse Large B-Cell Lymphoma.
Susanna Tokola, Katja Marin, Milla E L Kuusisto, Hanne Kuitunen, Marjukka Pollari

Cancer Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival of patients with classical Hodgkin lymphoma in Finland: a national population-based analysis.
Noora Hannuksela, Anu Partanen, Anna Anttalainen, Liisa Ukkola-Vuoti, Iiro Toppila, Katja Marin

Blood Cancer J· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood-Brain Barrier Disruption (BBBD)-Based Immunochemotherapy for Primary Central Nervous System Lymphoma (PCNSL), Early Results of a Phase II Study.
Hanne K Kuitunen, Aino L K Rönkä, Eila M Sonkajärvi, Juha-Matti Isokangas, Marja Pyörälä, Katja J Marin

Cancers (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic Cutaneous Disorders Are Associated with a More Favorable Disease Presentation and Outcome in Patients with Hodgkin Lymphoma.
Katja Marin, Päivi Auvinen, Hanne Kuitunen, Outi Kuittinen

Oncol Res Treat· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
R-Bendamustine in the treatment of nodular lymphocyte-predominant Hodgkin lymphoma.
Roosa Enni Inkeri Prusila, Kirsi-Maria Haapasaari, Katja Marin, Marjukka Pollari, Ylermi Soini

Acta Oncol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low Rap1-interacting factor 1 and sirtuin 6 expression predict poor outcome in radiotherapy-treated Hodgkin lymphoma patients.
Hamid Bur, Kirsi-Maria Haapasaari, Taina Turpeenniemi-Hujanen, Outi Kuittinen, Päivi Auvinen, Katja Marin

Leuk Lymphoma· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strong Prolyl Hydroxylase Domain 1 Expression Predicts Poor Outcome in Radiotherapy-treated Patients with Classical Hodgkin's Lymphoma.
Hamid Bur, Kirsi-Maria Haapasaari, Taina Turpeenniemi-Hujanen, Outi Kuittinen, Päivi Auvinen, Katja Marin

Anticancer Res· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strong KDM4B and KDM4D Expression Associates with Radioresistance and Aggressive Phenotype in Classical Hodgkin Lymphoma.
Hamid Bur, Kirsi-Maria Haapasaari, Taina Turpeenniemi-Hujanen, Outi Kuittinen, Päivi Auvinen, Katja Marin

Anticancer Res· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxidative stress markers and mitochondrial antioxidant enzyme expression are increased in aggressive Hodgkin lymphomas.
Hamid Bur, Kirsi-Maria Haapasaari, Taina Turpeenniemi-Hujanen, Outi Kuittinen, Päivi Auvinen, Katja Marin

Histopathology· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis